The risk of coronary artery disease remains under-appreciated in female patients, who suffer a disproportionate amount of microvascular disease and are much less likely than men to receive preventive treatments and recommendations despite facing higher mortality and morbidity rates, according to a review published in Global Heart. "Further research regarding the pathophysiology of CAD in women, diagnosis, and treatment strategies specific to women is required," wrote Drs. Martha Gulati and Kavita Sharma. "CAD is not a 'man's only' disease, and we eagerly await future studies that examine its unique presence in women."
Women's CAD risk, treatment are neglected, researchers argue
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|